We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Age of Stored Blood Affects Cardiac Surgery Success

By HospiMedica staff writers
Posted on 31 Mar 2008
A new study has found that cardiac surgery patients who received transfusions of blood that had been stored for 2 weeks or less had lower rates of complications and death than those who received blood that was older.

Researchers at the Cleveland Clinic Foundation (OH, USA) examined data from 6,002 patients given red blood cell (RBC) transfusions during coronary artery bypass grafting (CABG), heart-valve surgery, or both between June 30, 1998, and January 30, 2006. More...
The researchers compared a total 2,872 cardiac surgery patients who received transfusion blood that had been donated within the previous 2 weeks with 3,130 cardiac surgery patients who received transfusion blood that had been donated more than 2 weeks earlier. Multivariable logistic regression with propensity-score methods was used to examine the effect of the duration of storage on outcomes.

The researchers found that the patients who were given older blood had a higher risk of dying in hospital than their newer blood counterparts were (2.8% versus 1.7%), and significantly more likely to need prolonged ventilation support, experience kidney failure, sepsis, or multiple organ failure. Mortality at one year was significantly less in patients given newer blood (7.4%) compared to those given older blood (11%). The investigators also discovered a direct dose response relationship between days of storage and the chances of a combination of serious complications or adverse events. After eliminating potential confounding factors, an analysis revealed that patients who had received older blood had a significantly higher rate of combined serious adverse events than those who received newer blood. The study was published in the March 20, 2008, issue of the New England Journal of Medicine (NEJM).

"In patients undergoing cardiac surgery, transfusion of red cells that had been stored for more than two weeks was associated with a significantly increased risk of postoperative complications as well as reduced short-term and long-term survival,” concluded lead author Colleen Koch, M.D., M.S., and colleagues of the department of cardiothoracic anesthesia.

Previous studies have already raised questions about the shelf life of donated blood and attendant risks to patients. Some hospitals have brought in new procedures to minimize the use of donated blood during cardiac surgery, such as reducing anemia before surgery, using drugs to stop bleeding during and after surgery, collecting blood lost by the patient during surgery to be reused, and even discharging patients with a lower than normal RBC count.


Related Links:
Cleveland Clinic Foundation

New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.